Medical Director, Dyslipidemia

Location: Wilmington, DelawareHybrid: 3 days a week onsiteAt AstraZeneca, we work together across global boundaries to make an impact and find answers to challenges. We do this with the utmost integrity even in the most difficult situations because we are committed to doing the right thing. We continuously forge partnerships that help pursue world-class medicines in new ways, combining our people's exceptional skills with those of people from all over the globe.The Medical Director - Dyslipidemia supports the development and execution of US Medical strategy for dyslipidemia and related assets.

This role translates disease area and brand priorities into actionable medical execution plans, coordinates cross-functional execution, and helps ensure medical activities are aligned to clinical, scientific, customer, healthcare environment, and business needs. The role requires understanding of the disease area and the evolving US healthcare environment. It also requires inspiring change at scale through coordinated medical strategy, external scientific engagement, and transforming care initiatives.

It is a key medical role that reports directly to the Medical Head - Dyslipidemia, within the BioPharmaceuticals Business Unit's US Medical CVRM franchise.What you'll do:Lead the development, delivery, and evolution of disease area and brand medical execution strategies and plansThrough partnership and innovative thinking, identify external insights, customer needs, healthcare environment trends and opportunities to transform care that inform medical planning and executionLead the development and execution of scalable and sustainable transforming care initiatives aligned to disease area and medical strategic priorities.Identify and advance opportunities to accelerate adoption of evidence-based care through partnerships with healthcare systems, scientific societies, quality organizations, and other external collaborators.Coordinate cross-functional medical initiatives across Medical Affairs, Commercial, HEOR, Market Access, R&D, Field Medical and other partners to ensure aligned execution and enable large-scale change in care deliveryMaintain and strengthen key External Scientific Engagement (ESE) relationships across healthcare systems and other collaborators to advance disease area priorities, scientific exchange, and transforming care objectives.Support the planning and implementation of product and disease area Advisory Boards, including objective development, collaborator engagement, insight generation, and follow-up action planning.Contribute to publication plans, evidence generation initiatives, medical education activities and scientific communication deliverablesPartner with Senior Medical Directors and cross-functional teams to provide medical input for regulatory, labeling, preparation for product introduction, and lifecycle management activitiesEssential for the role:MD, PhD, PharmD, or other advanced healthcare/scientific degreeMedical/clinical/scientific understanding of CVRM and dyslipidemia, with ability to apply disease area knowledge to medical planning, external engagement and execution 3+ years of experience in the pharmaceutical industry, ideally in Medical Affairs, Evidence Generation, HEOR, Clinical Development or a relevant Medical / Healthcare fieldStrategic and goal-oriented thinker with ability to translate complex medical priorities into clear plans, deliverables and approaches that inspire change at scaleDemonstrated track record delivering results in a complex matrix environment and supporting impactful medical initiativesProven ability to collaborate and build internal and external networksStrong analytical mind-set and ability to quickly assess large amounts of information and distil into key messages, implications and actionsExperience and/or appreciation of product launches, launch readiness and product life cycle managementPersuasive oral and written communication skills, including the ability to develop an